References
- Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE, editors. Textbook of pediatric rheumatology. 4th ed. Philadelphia: WB Saunders; 2001. p. 219–20.
- Schneider R, Passo MH. Juvenile rheumatoid arthritis. Rheum Dis Clin N Am 2002;28:503–30.
- Wu CJ, Huang JL, Yang MH, Yan DC, Ou LS, Ho HH. Clinical characteristics of juvenile rheumatoid arthritis in Taiwan. J Microbiol Immunol Infect 2001;34:211–14.
- Aggarwal A, Misra R. Juvenile chronic arthritis in India: is it different from that seen in Western countries? Rheumatol Int 1994;14:53–6.
- Fujikawa S, Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997;39: 245–9.
- Khuffash FA, Majeed HA. Juvenile rheumatoid arthritis among Arab children. Scand J Rheumatol 1988;17:393–5.
- Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997;24:1826–9.
- Gare BA, Fasth A. Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. Pediatrics 1992;90:950–8.
- Moe N, Rygg M. Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year retrospective study. Clin Exp Rheumatol 1998;16:99–101.
- Arguedas 0, Fasth A, Andersson-Gäre B, Porras 0. Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study. J Rheumatol 1998;25: 1844–50.
- Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Zink A, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2392–401.
- Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheuma-toid arthritis in a multicenter cohort. J Rheumatol 2002;29: 1989–99.
- Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol 1992;19 suppl 33:6–10.
- Giannini EH, Cawkwell GD. Drug treatment in children with juvenile rheumatoid arthritis: Past, present, and future. Pediatr Clin N Am 1995;42:1099–125.
- Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002;109:109–15.
- Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1977;S20:195–9.
- Chen CC, Lin YT, Yang YH, Chiang BL. Sulfasalazine therapy for juvenile rheumatoid arthritis. J Formos Med Assoc 2002;101:110–6.
- Lin YT, Yang YH, Tsai MJ, Chiang BL. Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis. J Formos Med Assoc 2000;99:330–5.
- Lin YT, Tsai MJ, Wang LH, Huang MT, Yang YH, Chiang BL. Efficacy and safety of methotrexate for juvenile rheumatoid arthritis. J Formos Med Assoc 2000;99:623–9.
- Oen KG, Cheang M. Epidemiology of chronic arthritis in childhood. Sem Arthritis Rheum 1996;26:575–91.
- Flato B, Lien G, Smerdel A, Vinje 0, Dale K, Forre 0, et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 2003;30: 386–93.
- Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, et al. Health status of patients with JRA at 1 and 5 years after diagnosis. J Rheumatol 2003;30:394–400.
- Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975;18:251–5.
- Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol. 2001;28:1083–90.
- Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. I. Onset and disease process. J Rheumatol. 1995;22:295–307.
- Tower SR, Michet CJ, O'Fallon WM, Nelson AM. The epidemiology of juvenile arthritis in Rochester, Minnesota 1960–1979. Arthritis Rheum 1983;26: 1208–13.
- Andersson-Gare B, Fasth A, Andersson J, Berglund G, Ekstrom H, Thilen A, et al. Incidence and prevalence of juvenile chronic arthritis: a population survey. Ann Rheum Dis 1987;46:277–81.
- Petty RE, Cassidy JT, Sullivan DB. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. J Pediatr 1973;83:386–9.
- Rosenberg AM, Cordeiro DM, Knaus RP. Studies on the specificity of antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1983;26:S57.
- Oh KT, Hong KP, Kim TH, Jun JB, Jung SS, Kim SY, et al. High incidence of HLA-B27 and low incidence of ANA in Korean juvenile rheumatoid arthritis: a descriptive cross-sectional study to analyze profiles related to prognosis. Arthritis Rheum 1996;39 suppl:S54.
- Kotaniemi K, Kotaniemi A, Savolainen A. Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis. Clin Exp Rheumatol 2002;20: 109–12.
- Lehman TJA. Aggressive therapy for childhood rheumatic disease: when are immunosuppressives appropriate. Arthritis Rheum 1993;36:71–4.
- Cron RQ, Sharma S, Sherry DD. Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol 1999;26:2036–8.
- Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin N Am 1991;17:891–905.
- Petty RE. Prognosis in children with rheumatic disease: justification for consideration of new therapies. Rheumatology 1999;38:739–42.
- Flato B, Aasland A, Vinje 0, Form 0. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 1998;25:366–75.
- Lomater C, Gerloni V, Gattinara M, Mazzotti J, Cimaz R, Fantini F. Systemic onset juvenile idiopathic arthritis: A retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000;27:491–6.
- Prieur AM. HLA B27 associated chronic arthritis in children: review of 65 cases. Scand J Rheumatol 1987;66 Supp1:51–6.
- Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. II: outcome. J Rheumatol 1995;22:308–19.